temozolomide has been researched along with cycloviolacin o2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banack, SA; Cox, PA; Dunlop, RA; Gerlach, SL; Metcalf, JS | 1 |
1 other study(ies) available for temozolomide and cycloviolacin o2
| Article | Year |
|---|---|
Cyclotides Chemosensitize Glioblastoma Cells to Temozolomide.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cyclotides; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glioblastoma; Humans; Mice; Proof of Concept Study; Temozolomide; Xenograft Model Antitumor Assays | 2022 |